Price Alert: Shares of Resmed (RMD) Trade 3.69% Higher at Midday May 13
Equities Staff Follow |Resmed Inc. (NYSE: RMD) shares climbed 3.69%, or $7.095 per share, as on 12:06:13 est today. After Opening the Day at $195.86, 167,407 shares of Resmed exchanged hands and the stock has moved between $200.27 and $194.40.
This year the company has moved YTD 25.88%.
Resmed anticipates its next earnings on 2022-08-04.
For technical charts, analysis, and more on Resmed visit the company profile.
About Resmed Inc.
ResMed pioneers innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Its comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, the company improves quality of life, reduces the impact of chronic disease, and lowers costs for consumers and healthcare systems in more than 140 countries.
To get more information on Resmed Inc. and to follow the company's latest updates, you can visit the company's profile page here: Resmed Inc.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.
Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.
Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer